| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem, 91120; Department of Medicine, Evanston Northwestern Healthcare, 2650 Ridge Ave, Evanston IL, 60201
* To whom correspondence should be addressed. Email:
jstrahilevitz{at}hadassah.org.il.
Clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 through 2005 at a tertiary care center were studied for qnr genes. Isolates bearing these genes emerged in the mid-1990s, coinciding with the time of rapid increase in fluoroquinolone resistance. 60% of these isolates were ciprofloxacin susceptible by CLSI breakpoints.
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp.; 1990-2005
![]()
Abstract
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |